BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 33614199)

  • 1. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
    Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
    Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
    Emamikhah M; Babadi M; Mehrabani M; Jalili M; Pouranian M; Daraie P; Mohaghegh F; Aghavali S; Zaribafian M; Rohani M
    J Neurovirol; 2021 Feb; 27(1):26-34. PubMed ID: 33492608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
    Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
    J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.
    Fernandes J; Puhlmann P
    J Neurovirol; 2021 Jun; 27(3):501-503. PubMed ID: 33788141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.
    Finsterer J; Scorza FA
    Neuroophthalmology; 2023; 47(1):1-6. PubMed ID: 36798867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.
    Ismail II; Kamel WA; Kilany A
    Acta Neurol Belg; 2023 Apr; 123(2):715-716. PubMed ID: 35836090
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.
    Olbert E; Alhani N; Struhal W
    Wien Med Wochenschr; 2024 Feb; 174(1-2):30-34. PubMed ID: 37523107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsoclonus-myoclonus syndrome attributable to hepatitis C infection.
    Ertekin V; Tan H
    Pediatr Neurol; 2010 Jun; 42(6):441-2. PubMed ID: 20472199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.
    Przytuła F; Błądek S; Sławek J
    Neurol Neurochir Pol; 2021; 55(3):310-313. PubMed ID: 34096013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report.
    Werner J; Reichen I; Huber M; Abela IA; Weller M; Jelcic I
    BMC Infect Dis; 2021 Mar; 21(1):298. PubMed ID: 33761897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.
    Wiegand SE; Mitchell WG; Santoro JD
    Mult Scler Relat Disord; 2021 May; 50():102855. PubMed ID: 33677410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para-infectious syndrome associated with COVID-19.
    Foucard C; San-Galli A; Tarrano C; Chaumont H; Lannuzel A; Roze E
    Eur J Neurol; 2021 Oct; 28(10):3533-3536. PubMed ID: 33492711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-malarial opsoclonus-myoclonus-ataxia syndrome: a paediatric case].
    Suárez-Galvis MM; Benjumea-Cuartas V; Mesa-Restrepo SC; Cabrera D
    Rev Neurol; 2011 Apr; 52(7):444-6. PubMed ID: 21425115
    [No Abstract]   [Full Text] [Related]  

  • 15. Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma.
    Maller B; Peguero E; Tanvetyanon T
    J Immunother; 2018; 41(9):411-412. PubMed ID: 29742520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-Myoclonus-Ataxia Syndrome Related to the Novel Coronavirus (COVID-19).
    Sanguinetti SY; Ramdhani RA
    J Neuroophthalmol; 2021 Sep; 41(3):e288-e289. PubMed ID: 32925477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.
    Ishaq H; Durrani T; Umar Z; Khan N; McCombe P; Ul Haq MA
    Front Neurol; 2021; 12():672524. PubMed ID: 34163427
    [No Abstract]   [Full Text] [Related]  

  • 18. 78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19.
    Saha B; Saha S; Chong WH
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34049895
    [No Abstract]   [Full Text] [Related]  

  • 19. Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and dengue virus co-infection.
    do Rosário MS; Giovanetti M; de Jesus PAP; Farias DS; Faria NR; de Lima CPS; da Silva SP; Nunes MR; Alcantara LCJ; de Siqueira IC
    Int J Infect Dis; 2018 Oct; 75():11-14. PubMed ID: 30076990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate response in adult-onset opsoclonus-myoclonus-ataxia syndrome: A case report.
    Degirmenci Y; Kececi H
    Rev Neurol (Paris); 2017 Jun; 173(6):418-420. PubMed ID: 28461028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.